Psychology Events & Seminars
2021 Events and Seminars
A Talk By Dr. Cornelia Wieman
Dr. Cornelia Wieman, MSc, MD, FRCPC
The Department of Psychology’s Indigenous Reconciliation Committee will be hosting a talk by featuring Canada's first female Indigenous psychiatrist, Dr. Cornelia (Nel) Wieman, MSc, MD, FRCPC.
Cornelia (Nel) Wieman, Anishinaabe (Little Grand Rapids First Nation, Manitoba), is the Acting Deputy Chief Medical Officer for the First Nations Health Authority and has served as the President of the Indigenous Physicians Association of Canada (IPAC) since 2016. Dr. Wieman’s specializations include COVID-19 Response, Vaccine Confidence, Mental Health and Wellness, Addictions, Trauma-Informed Practice, Cannabis, Communications and Wellness Initiatives. Dr. Wieman completed her medical degree and psychiatry specialty training at McMaster University. As Canada's first female Indigenous psychiatrist, Dr. Wieman has more than 20 years' clinical experience, working with Indigenous people in both rural/reserve and urban settings. Her previous activities include co-directing an Indigenous health research program in the Dalla Lana School of Public Health at the University of Toronto and the National Network for Indigenous Mental Health Research, being Deputy Chair of Health Canada's Research Ethics Board, and serving on CIHR's Governing Council. She has also worked and taught in many academic settings, has chaired national advisory groups within First Nations Inuit Health Branch - Health Canada, and has served as a Director on many boards, including the Indspire Foundation, Pacific Blue Cross and the National Consortium on Indigenous Medical Education.
Psychology Department Colloquium
Dr. Geoff MacDonald, University of Toronto
Singlehood and Sexuality
Worldwide, long-term singlehood is on the rise and understanding predictors of well-being in singlehood is becoming increasingly important. Sexual satisfaction may be a particularly important predictor given that the sexual aspects of romantic relationships are harder to replace than other aspects like emotional support. In Part 1 of my talk I will provide evidence that sexual satisfaction is an important predictor of life satisfaction and satisfaction with singlehood. In Part 2 of my talk I will provide evidence that sexual satisfaction for singles is particularly low amongst those who desire partnered sexual activities but are not experiencing them. In Part 3 of my talk I will use qualitative reports of singles’ sexual and dating lives to examine who sexually active singles are having partnered sexual experiences with. Overall, I argue that understanding long-term singlehood must involve understanding how singles resolve their sexual desires.
Dr. Zach Walsh, University of British Columbia
Macrodosing, Microdosing, and Ketamine Assisted Psychotherapy: New Developments in the Psychedelic Renaissance
The past decade has witnessed a dramatic increase in interest in the therapeutic application of psychedelic medicines including “classic” 5HT2A receptor agonists such as psilocybin and LSD, and associated medicines such as ketamine. This presentation will focus on research from our group examining mechanisms that might underly the actions of large (macro) doses of classic psychedelics and implications for psychedelic psychotherapy. We will also examine new findings regarding the use of smaller (micro) doses of psychedelics for improving mental health and well- being. Finally, we will explore the use of ketamine in mental health and the potential role of ketamine-assisted psychotherapy in the broader psychedelic landscape.
Zach Walsh, PhD, is a clinical psychologist, a Research Affiliate with the BC Centre on Substance Use, and a Professor of Psychology at the University of British Columbia, where he directs the Therapeutic, Recreational, and Problematic Substance Use lab and the Problematic Substance Use clinic. Zach is a member of the Advisory Board of MAPS Canada and a member of the International Research Society on Psychedelics. He has published and presented widely on topics related to psychedelics, cannabis, mental health and psychotherapy, and is an investigator on several ongoing studies of psychedelics and cannabis.
Dr. Evelyn Stewart, University of British Columbia
Title: Risk, Manifestation and Treatment of Pediatric Obsessive-Compulsive Disorder
OCD is a disabling, childhood-onset illness affecting 1-3% of the population. Known to be a complex genetic disorder, environmental and other factors have important influences on its onset and expression. In this talk, genetic, endophenotypic and neuroimaging aspects of OCD will be discussed, including a genome-wide association study and a more recent cohort study led by the presenter. Moreover, aspects of OCD manifestation will be explored, with reference to emergent findings from an international collaboration of pediatric OCD researchers. Finally, evidence-based standards of treatment for this disorder will be reviewed, in addition to novel approaches to treatment provision and family support.
Dr. S. Evelyn Stewart is a child and adolescent psychiatrist, and a clinical and neuroscience researcher. She is a Professor in the Department of Psychiatry at the University of British Columbia (UBC) and is the founding director of the BC Children’s Hospital (BCCH) Provincial Obsessive-Compulsive Disorder Clinic and Research Program. She is also the Research Director for BCCH Child, Youth and Reproductive Mental Health program and a member of BC Mental Health & Substance Use Services. She leads the Brain, Behaviour & Development theme at the BCCH Research Institute.